Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Risk Adapted Antifungal Strategy in Allogeneic Stem Cell Transplantation. Should We Change the Current Guidelines?

Lucrecia Yanez San Segundo, MD PhD, Noemi Fernandez Escalada, MD, Arancha Bermúdez, MD, Guillermo Martín Sánchez, MD, Sara García Avila, MD, Mónica López Duarte, MD, Mercedes Colorado, MD, Iñigo Romon, MD PhD, Carlos Richard, MD, Enrique M. Ocio, MD PhD

Blood (2019) 134 (Supplement_1): 5655.

https://doi.org/10.1182/blood-2019-130731

Published: 2019

Journal Articles

Post-Transplantation Cyclophosphamide Versus Low Doses ATG Fresenius As Part of Two Immunosuppression Regimens for Graft Versus Host Disease Prophylaxis: Low Severe Graft Versus Host Disease (GVHD) Incidence and y Similar Gvhd-Free and Relapse-Free Survival (GRFS)

Cristina Fernández Martínez, Arancha Bermúdez, MD, Sara García Ávila, MD, Borja San Pedro, Almudena Cabero Martínez, MD, Lucrecia Yáñez, MD PhD, Mónica López Duarte, Mercedes Colorado, MD, Sonia González de Villambrosia, MD, Joan Manuel Mora, MD, Yolanda Gonzalez Romero, MD, David Gomez, MD, Sara Fenandez Luis, MD, Irati Ormazabal, MD, Andrés Insunza, Iñigo Romon, MD PhD, Jose Luis Arroyo, MD, Eulogio Conde, MD PhD, Carlos Richard, MD

Blood (2018) 132 (Supplement 1): 5716.

https://doi.org/10.1182/blood-2018-99-114124

Published: 2018

Journal Articles

Very Low Dose of Anti-T-Lymphocyte Globulin Protects Against Severe Forms of Graft Versus Host Disease in High Risk Patients: The Experience in Our Center

Joan Manuel Mora, MD, Arancha Bermúdez, MD, Miguel Angel Cortés, MD, Yolanda González Romero, MD, Mercedes Colorado, MD, Cristina Fernández Martínez, MD, Almudena Cabero Martínez, MD, David Gómez, MD, Sara Fernández Luis, MD, Sara García Ávila, MD, Lucrecia Yáñez, MD PhD, Irati Ormazabal, MD, Guillermo Martín Sánchez, MD, Jose Luis Arroyo, MD, Javier Núñez, MD, Iñigo Romón, MD PhD, Eulogio Conde, MD PhD, Carlos Richard, MD

Blood (2018) 132 (Supplement 1): 5723.

https://doi.org/10.1182/blood-2018-99-118664

Published: 2018

Journal Articles

Efficacy and Safety of a Biosimilar Granulocyte-Colony Stimulating Factor for Stem Cell Mobilization before Autologous Hematopoietic Stem Cell Transplantation

Guillermo Martín-Sánchez, MD, Cristina Amunarriz, MD, Miriam Sanchez, Maria Aranzazu Bermudez, MD, Lucrecia Yañez, MD PhD, Mercedes Colorado, MD, Carlos Richard, MD, Eulogio Conde, MD PhD, Jose Luis Arroyo, MD PhD

Blood (2016) 128 (22): 5737.

https://doi.org/10.1182/blood.V128.22.5737.5737

Published: 2016

Journal Articles

Differences of Antithymocyte Globulin (ATG) Side Effects during Allogeneic Stem Cell Transplantation

Lucrecia Yañez San Segundo, MD PhD, Brenda Lopez Pereira, MD, Maria Aranzazu Bermudez, MD, Andres Insunza, Iñigo Romon, MD PhD, Carlos Richard, MD, Eulogio Conde, MD PhD

Blood (2015) 126 (23): 5449.

https://doi.org/10.1182/blood.V126.23.5449.5449

Published: 2015

Journal Articles

Low Dose ATG-Fresenius Might be Effective in the Prophylaxis of Severe Graft Versus Host Disease with Low Non-Relapse Mortality

Irati Ormazabal Velez, Maria Aranzazu Bermudez, MD, Andres Insunza, Lucrecia Yañez, Carlos Richard, MD, Eulogio Conde, MD PhD

Blood (2015) 126 (23): 5468.

https://doi.org/10.1182/blood.V126.23.5468.5468

Published: 2015

Journal Articles

Allogeneic Stem Cell Transplantation for MDS Patients More Than 70 Years of Age: a Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party (CMWP) of the EBMT

Blood (2015) 126 (23): 4390.

https://doi.org/10.1182/blood.V126.23.4390.4390

Published: 2015

Journal Articles

Impact of Neurological Complications on the Overall Survival in Allogeneic Stem Cell Transplantation

Paloma Ibarrondo, Arancha Bermudez, MD, Irati Ormazabal, Lucrecia Yáñez, MD, Carmen Montes-Gaisán, MD, Carlos De Miguel, Carlos Richard, MD, Andrés Insunza, MD, Eulogio Conde, MD PhD

Blood (2014) 124 (21): 3894.

https://doi.org/10.1182/blood.V124.21.3894.3894

Published: 2014

Journal Articles

Efficacy and Cost-Effectiveness of a Different Schedule for the Prevention of Fungal Infections during the Early Phase of Stem Cell Transplantation

Lucrecia Yáñez, MD, Noemí Fernández, MD, Arancha Bermudez, MD, Germán Pérez, MD, Andres Insunza, MD, Carlos Richard, MD, Eulogio Conde, MD PhD

Blood (2014) 124 (21): 1154.

https://doi.org/10.1182/blood.V124.21.1154.1154

Published: 2014

Journal Articles

Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome; A More Favorable Outcome after Fludarabine and Treosulfan Conditioning. a Survey on Behalf of the Chronic Malignancies Working Party of the EBMT

Avichai Shimoni, MD, Arnon Nagler, MD, Simona Iacobelli, PhD, Anja van Biezen, Dietrich Beelen, Ghulam J. Mufti, DM, FRCP, FRCPath, Fabio Ciceri, MD, Lothar Kanz, MD, Liisa Volin, MD, Carlos Richard, MD, Didier Blaise, MD PhD, Arnold Ganser, Thomas Luft, MD PhD, Patrice Chevallier, MD PhD, Rainer Schwerdtfeger, Theo de Witte, MD, Marie Robin, MD PhD, Nicolaus Kröger, MD

Blood (2014) 124 (21): 1216.

https://doi.org/10.1182/blood.V124.21.1216.1216

Published: 2014

Journal Articles

Survival Outcome and Long-Term Follow-up of Autologous and Allogeneic Stem Cell Transplantation (SCT) in Acute Myeloid Leukemia (AML): A 30 Years Single-Center Experience

Carmen Montes-Gaisán, MD, German Perez, MD, Arancha Bermudez, MD, Amalia Cuesta, MD, Carlos Richard, MD, Eulogio Conde, MD PhD

Blood (2014) 124 (21): 5890.

https://doi.org/10.1182/blood.V124.21.5890.5890

Published: 2014

Journal Articles

Progressive Increase Of Thymoglobulin Severe Infusion Reactions Used In The Conditioning Regimen Of Allogeneic Stem Cell Transplantation. Comparative Study Between 2004 and 2012

Lucrecia Yanez, MD, Brenda López Pereira, Arancha Bermudez, MD, Andres Insunza, MD, Carlos Richard, MD, Mario Gonzalez Ruiz, M.D, Esmeralda Cuaresma, MD, Eulogio Conde, MD, PhD

Blood (2013) 122 (21): 5451.

https://doi.org/10.1182/blood.V122.21.5451.5451

Published: 2013

Journal Articles

Outcome Depend On Age But Not Comorbidity Score, In Patients treated With Fludarabine and Busulfan (FB4) As Conditioning Regimen In Allogeneic Stem Cell Transplantation

Javier Nunez, MD, Arancha Bermudez, MD, Lucrecia Yanez, MD, Guillermo Martin, MD, Andres Insunza, MD, Carlos Richard, MD, Carmen Montes Gaisan, MD, Eulogio Conde, MD, PhD

Blood (2013) 122 (21): 4533.

https://doi.org/10.1182/blood.V122.21.4533.4533

Published: 2013

Journal Articles

Allogeneic Stem Cell Transplantation (allo-SCT) in 192 Acute Myeloid Leukemias (AML): A Single Center Experience From 1982 to 2010

Carmen Montes-Gaisan, MD, Jorge Monge, MD, Clara Martin, MD, Zurie Diez, MD, Johny Alberto Hinostroza, MD, Javier Nuez, MD, Marta Albajar, MD, Carlos Richard, MD, Eulogio Conde, Sr., MD, PhD, Arturo Iriondo, MD

Blood (2011) 118 (21): 4498.

https://doi.org/10.1182/blood.V118.21.4498.4498

Published: 2011

Journal Articles

Autologous Stem Cell Transplantation (ASCT) in 121 Acute Myeloid Leukemias (AML): A Single Center Experience From 1988 to 2010

Carmen Montes-Gaisan, MD, Amalia Cuesta, MD, Susana Herraez, MD, German Perez, MD, Guillermo Martin, MD, Arancha Bermudez, MD, Andres Insunza, MD, Carlos Richard, MD, Eulogio Conde, MD, PhD, Arturo Iriondo, MD

Blood (2011) 118 (21): 3099.

https://doi.org/10.1182/blood.V118.21.3099.3099

Published: 2011

NARROW

Risk Adapted Antifungal Strategy in Allogeneic Stem Cell Transplantation. Should We Change the Current Guidelines?

Post-Transplantation Cyclophosphamide Versus Low Doses ATG Fresenius As Part of Two Immunosuppression Regimens for Graft Versus Host Disease Prophylaxis: Low Severe Graft Versus Host Disease (GVHD) Incidence and y Similar Gvhd-Free and Relapse-Free Survival (GRFS)

Very Low Dose of Anti-T-Lymphocyte Globulin Protects Against Severe Forms of Graft Versus Host Disease in High Risk Patients: The Experience in Our Center

Efficacy and Safety of a Biosimilar Granulocyte-Colony Stimulating Factor for Stem Cell Mobilization before Autologous Hematopoietic Stem Cell Transplantation

Differences of Antithymocyte Globulin (ATG) Side Effects during Allogeneic Stem Cell Transplantation

Low Dose ATG-Fresenius Might be Effective in the Prophylaxis of Severe Graft Versus Host Disease with Low Non-Relapse Mortality

Allogeneic Stem Cell Transplantation for MDS Patients More Than 70 Years of Age: a Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party (CMWP) of the EBMT

Impact of Neurological Complications on the Overall Survival in Allogeneic Stem Cell Transplantation

Efficacy and Cost-Effectiveness of a Different Schedule for the Prevention of Fungal Infections during the Early Phase of Stem Cell Transplantation

Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome; A More Favorable Outcome after Fludarabine and Treosulfan Conditioning. a Survey on Behalf of the Chronic Malignancies Working Party of the EBMT

Survival Outcome and Long-Term Follow-up of Autologous and Allogeneic Stem Cell Transplantation (SCT) in Acute Myeloid Leukemia (AML): A 30 Years Single-Center Experience

Progressive Increase Of Thymoglobulin Severe Infusion Reactions Used In The Conditioning Regimen Of Allogeneic Stem Cell Transplantation. Comparative Study Between 2004 and 2012

Outcome Depend On Age But Not Comorbidity Score, In Patients treated With Fludarabine and Busulfan (FB4) As Conditioning Regimen In Allogeneic Stem Cell Transplantation

Allogeneic Stem Cell Transplantation (allo-SCT) in 192 Acute Myeloid Leukemias (AML): A Single Center Experience From 1982 to 2010

Autologous Stem Cell Transplantation (ASCT) in 121 Acute Myeloid Leukemias (AML): A Single Center Experience From 1988 to 2010

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only